Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 12/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | HPGD | P15428 | 3/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PLK1 | P53350 | 1/20 | 0.47 |
| ▸ | DHODH | Q02127 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.45 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7677649 | 0.87 | KDM4E (0.57) | KDM4EALDH1A1HPGDNPSR1POLB | |
| SCHEMBL976330 | 0.85 | KDM4E (0.57) | KDM4EALDH1A1HPGDNPSR1POLB | |
| SCHEMBL406268 | 0.85 | HTT (0.49) | KDM4EALDH1A1HPGDNPSR1POLB | |
| SCHEMBL8586325 | 0.83 | KDM4E (0.45) | KDM4EALDH1A1HPGDNPSR1POLB | |
| SCHEMBL10892729 | 0.83 | KDM4E (0.45) | KDM4EALDH1A1HPGDNPSR1L3MBTL1 | |
| SCHEMBL17240274 | 0.83 | MAPT (0.50) | KDM4EALDH1A1HPGDNPSR1POLB | |
| SCHEMBL20123231 | 0.83 | KDM4E (0.52) | KDM4EALDH1A1HPGDNPSR1POLB | |
| SCHEMBL2131809 | 0.82 | KDM4E (0.59) | KDM4EALDH1A1HPGDNPSR1 | |
| SCHEMBL8966782 | 0.82 | KDM4E (0.59) | KDM4EALDH1A1HPGDNPSR1POLB | |
| SCHEMBL5963042 | 0.81 | HMGCR (0.53) | KDM4EALDH1A1HPGDNPSR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4290637-A1 | METAL M-AIR BATTERY CELL COMPRISING AN ORGANIC MULTI REDOX MEDIATOR COMPOUND AS SOLUBLE ORGANIC CATALYST | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2023-12-13 | — | — | EP | disclosed |
| EP-4290637-A1 | METAL M-AIR BATTERY CELL COMPRISING AN ORGANIC MULTI REDOX MEDIATOR COMPOUND AS SOLUBLE ORGANIC CATALYST | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2023-12-13 | — | — | EP | disclosed |
| US-20230086413-A1 | PHOTORADICAL POLYMERIZABLE COMPOSITION | AIR WATER PERFORMANCE CHEMICAL INC. (JP) | 2023-03-23 | — | — | US | disclosed |
| EP-2203161-B1 | QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | UNIV INDIANA RES & TECH CORP (US) | 2018-05-09 | — | — | EP | disclosed |
| EP-2203161-B1 | QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | UNIV INDIANA RES & TECH CORP (US) | 2018-05-09 | — | — | EP | disclosed |
| US-9089605-B2 | Quinone derivatives, pharmaceutical compositions, and uses thereof | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-07-28 | — | — | US | disclosed |
| US-9089605-B2 | Quinone derivatives, pharmaceutical compositions, and uses thereof | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-07-28 | — | — | US | disclosed |
| US-9089605-B2 | Quinone derivatives, pharmaceutical compositions, and uses thereof | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-07-28 | — | — | US | disclosed |
| US-20100297113-A1 | QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | PURDUE RESEARCH FOUNDATION | 2010-11-25 | — | — | US | disclosed |
| US-20100297113-A1 | QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | PURDUE RESEARCH FOUNDATION | 2010-11-25 | — | — | US | disclosed |
| US-7304046-B2 | Phosphoramide compounds | PURDUE RESEARCH FOUNDATION (US) | 2007-12-04 | — | — | US | disclosed |
| US-7304046-B2 | Phosphoramide compounds | PURDUE RESEARCH FOUNDATION (US) | 2007-12-04 | — | — | US | disclosed |
| US-20040176332-A1 | Phosphoramide compounds | PURDUE RESEARCH FOUNDATION | 2004-09-09 | — | — | US | disclosed |
| US-6656926-B2 | For therapy and prophylaxis of cancer | PURDUE RESEARCH FOUNDATION | 2003-12-02 | — | — | US | disclosed |
| US-20030008850-A1 | For therapy and prophylaxis of cancer | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-01-09 | — | — | US | disclosed |
| EP-0549366-B1 | Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses | SANKYO CO (JP) | 1998-04-15 | — | — | EP | disclosed |
| EP-0549365-B1 | Thiazolidine compounds, their preparation and their therapeutic uses | SANKYO CO (JP) | 1995-08-09 | — | — | EP | disclosed |
| US-5338855-A | Treating diabetes or hyperlipemia | SANKYO COMPANY, LIMITED (JP) | 1994-08-16 | — | — | US | disclosed |
| EP-0549366-A1 | Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses | Sankyo Company Limited (JP) | 1993-06-30 | — | — | EP | disclosed |
| EP-0549365-A1 | Thiazolidine compounds, their preparation and their therapeutic uses | Sankyo Company Limited (JP) | 1993-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297113-A1 | QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | APEX1, NQO1, REV1 | KDM4E 2642/4885ALDH1A1 210/4885HPGD 288/4885 |
| US-20040176332-A1 | Phosphoramide compounds | RB1, RRM2B, RRM1 | KDM4E 3140/4885ALDH1A1 1067/4885HPGD 3800/4885 |
| US-20030008850-A1 | For therapy and prophylaxis of cancer | BRCA1, RRM2B, FOLR1 | KDM4E 3105/4885ALDH1A1 27/4885HPGD 1306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.